The Myeloid Panel is a robust NGS assay that interrogates 58 genes of interest* most relevant to myeloid cancers. The panel uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology, a tiled amplicon-based library prep chemistry, designed by AI-empowered VersaTile™ Primer Design tool, for efficient single-tube target enrichment.
| ABL1 | BRAF | CEBPA | ETV6 | HRAS | KDM6A | NPM1 | PTEN | SMC1A | TP53 |
| ANKRD26 | CALR | CSF3R | EZH2 | IDH1 | KIT | NRAS | PTPN11 | SMC3 | U2AF1 |
| ASXL1 | CBL | CUX1 | FLT3 | IDH2 | KMT2A | PDGFRA | RAD21 | SRSF2 | WT1 |
| ATRX | CBLB | DDX41 | GATA1 | IKZF1 | KRAS | PHF6 | RUNX1 | STAG1 | ZRSR2 |
| BCOR | CBLC | DNMT3A | GATA2 | JAK2 | MPL | PIGA | SETBP1 | STAG2 | |
| BCORL1 | CDKN2A | ETNK1 | GNAS | JAK3 | NF1 | PPM1D | SF3B1 | TET2 |
Genes marked in green indicate full CDS coverage
Maintain control of samples and results with single-tube, tiled amplification that can be performed in-house by any NGS lab.
Achieve variant detection as low as 1% VAF† without UIDs ‡ even with limited DNA input or poor sample quality.
Improve lab efficiency and reduce “no calls”, repeat testing, and difficult interpretation decisions
| Parameter | Description / Value |
|---|---|
| Enrichment chemistry | Multiplex PCR using tiled amplicons |
| Number of genes / amplicons | 58/766 |
| Number of targets | Full CDS coverage of 18 genes, hotspots in 40 additional genes, FLT3 ITDs; 107.9kb total size |
| Variant types | SNVs, indels, ITD (internal tandem duplicates) |
| Average amplicon size | 217bp |
| Recommended DNA input range | 20ng to 60ng (20ng recommended) |
| Sample types | DNA from whole blood, PBMCs |
| Mapping rate | 99.6% ± 0.2% |
| % on-target aligned reads | 92.0% ± 5.3% |
| Coverage uniformity (% targets with >0.2X mean coverage) | 96.8% ± 1.0% |
| Recommended Reads Per Sample | ~4 million paired-end reads |
*Mapping rate, % of on-target aligned reads, and coverage uniformity metrics are based on internal testing performed using reference standard materials.